COVID-19, corticosteroids and public health: a reappraisal

OBJECTIVES: To assess whether regulatory guidance on the use of dexamethasone in hospitalised COVID-19 patients is applicable to the larger population of COVID-19 cases. The surge in worldwide demand for dexamethasone suggests that the guidance, although correct, has not emphasised the danger of its...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, M., Brábek, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society for Public Health. Published by Elsevier Ltd. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180552/
https://www.ncbi.nlm.nih.gov/pubmed/34325124
http://dx.doi.org/10.1016/j.puhe.2021.05.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180552/
https://www.ncbi.nlm.nih.gov/pubmed/34325124
http://dx.doi.org/10.1016/j.puhe.2021.05.028

Ejemplares similares